IE
BLTE

Israel Englander’s Belite Bio BLTE Stock Holding History

Israel Englander’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.2M Sell
494,564
-75,524
-13% -$11.6M 0.03% 647
2026
Q1 		$90.9M Buy
570,088
+11,206
+2% +$1.88M 0.04% 489
2025
Q4 		$89.4M Buy
558,882
+538,141
+2,595% +$63.7M 0.04% 477
2025
Q3 		$1.53M Buy
+20,741
New +$1.36M ﹤0.01% 4283
2022
Q3 		– Sell
-8,995
Closed -$280K – 7068
2022
Q2 		$280K Buy
+8,995
New +$169K ﹤0.01% 5425

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's BLTE Position: Q2 2026 in Review

Israel Englander reduced its Belite Bio (BLTE) stake by 13% in Q2 2026, selling an estimated $11.6M and leaving 494,564 shares worth $76.2M. The position accounts for 0.03% of the portfolio, ranked #647.

Israel Englander first reported a position in BLTE in Q2 2022 and has held it in 5 quarters since. The position peaked at $90.9M in Q1 2026. 81 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Israel Englander held 494,564 shares of Belite Bio worth $76.2M as of Q2 2026.
  • Israel Englander sold 75,524 Belite Bio shares in Q2 2026, an estimated $11.6M.
  • Belite Bio made up 0.03% of Israel Englander's portfolio in Q2 2026, its #647 holding.
  • Israel Englander first reported a position in Belite Bio in Q2 2022 and has held it in 5 quarters since.
  • Israel Englander's Belite Bio position peaked at $90.9M in Q1 2026.
  • 81 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.